Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study

Maria Saumoy, Jose Luís Sánchez-Quesada, Lambert Assoumou, José Maria Gatell, Ana González-Cordón, Giovanni Guaraldi, Pere Domingo, Andrea Giacomelli, Jérôme Connault, Christine Katlama, Mar Masiá, Jordi Ordónez-Llanos, Anton Pozniak, Esteban Martínez, Daniel Podzamczer

Open source

DOI
10.1093/jac/dkac117
Published
2022-04-13
Container
Journal of Antimicrobial Chemotherapy
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkac117,
  title = {Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study},
  author = {Maria Saumoy and Jose Luís Sánchez-Quesada and Lambert Assoumou and José Maria Gatell and Ana González-Cordón and Giovanni Guaraldi and Pere Domingo and Andrea Giacomelli and Jérôme Connault and Christine Katlama and Mar Masiá and Jordi Ordónez-Llanos and Anton Pozniak and Esteban Martínez and Daniel Podzamczer},
  year = {2022},
  journal = {Journal of Antimicrobial Chemotherapy},
  doi = {10.1093/jac/dkac117},
  url = {https://doi.org/10.1093/jac/dkac117}
}

RIS

TY  - JOUR
TI  - Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
AU  - Maria Saumoy
AU  - Jose Luís Sánchez-Quesada
AU  - Lambert Assoumou
AU  - José Maria Gatell
AU  - Ana González-Cordón
AU  - Giovanni Guaraldi
AU  - Pere Domingo
AU  - Andrea Giacomelli
AU  - Jérôme Connault
AU  - Christine Katlama
AU  - Mar Masiá
AU  - Jordi Ordónez-Llanos
AU  - Anton Pozniak
AU  - Esteban Martínez
AU  - Daniel Podzamczer
PY  - 2022
JO  - Journal of Antimicrobial Chemotherapy
DO  - 10.1093/jac/dkac117
UR  - https://doi.org/10.1093/jac/dkac117
ER  - 

APA

Saumoy, M., Sánchez-Quesada, J. L., Assoumou, L., Gatell, J. M., González-Cordón, A., Guaraldi, G., Domingo, P., Giacomelli, A., Connault, J., Katlama, C., Masiá, M., Ordónez-Llanos, J., Pozniak, A., Martínez, E., & Podzamczer, D. (2022). Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkac117

Source records